AII
ACAD icon

AGF Investments Inc’s Acadia Pharmaceuticals ACAD Stock Holding History

AGF Investments Inc’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,101
Closed -$245K – 422
2022
Q1 		$245K Sell
10,101
-7,477
-43% -$181K ﹤0.01% 421
2021
Q4 		$410K Buy
17,578
+6,378
+57% +$128K ﹤0.01% 494
2021
Q3 		$186K Buy
11,200
+2,664
+31% +$51.4K ﹤0.01% 567
2021
Q2 		$208K Buy
+8,536
New +$193K ﹤0.01% 550

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AGF Investments Inc's ACAD Position: Q2 2022 in Review

AGF Investments Inc sold out of Acadia Pharmaceuticals (ACAD) in Q2 2022, closing a stake of 10,101 shares — an estimated $245K sold.

AGF Investments Inc first reported a position in ACAD in Q2 2021 and held it in 4 quarters. The position peaked at $410K in Q4 2021. 246 funds tracked by Wall St. Rank hold ACAD as of Q2 2022.

  • AGF Investments Inc reported no remaining Acadia Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • AGF Investments Inc sold 10,101 Acadia Pharmaceuticals shares in Q2 2022, an estimated $245K.
  • AGF Investments Inc first reported a position in Acadia Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • AGF Investments Inc's Acadia Pharmaceuticals position peaked at $410K in Q4 2021.
  • 246 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2022.

Based on AGF Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.